CompletedNCT02023606
How the Body Processes SPN-810M in Healthy Male Volunteers
About this title
Read the official source — NCT02023606Medication studyAges 30–55United KingdomADHD
Understand this study
Who was this study for?
Listed age limits: 30 years to 55 years.
- Listed locations
- RuddingtonSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateNovember 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 7
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United Kingdom
- Age range
- From 30 Years to 55 Years
- Official registry ID
- NCT02023606
- Official title
Show the full official title
An Open-Label, Single-Dose, Mass-Balance Study to Assess the Absorption, Metabolism, and Excretion (AME) of [14C] Labeled SPN-810M in Healthy Adult Male Volunteers
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Ruddington
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Supernus Pharmaceuticals, Inc., a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including SPN-810M.
Who was this study for?
Listed age limits: 30 years to 55 years.
